Clusterin is a serum glycoprotein endowed with cell aggregating, complement inhibitory, and lipid binding properties, and is also considered as a specific marker of dying cells, its expression being increased in various tissues undergoing programmed cell death (PCD). However, no study has so far directly shown that cells expressing clusterin in these tissues are actually apoptotic as defined by morphological and biochemical criteria.
Introduction
Clusterin is a heterodimeric glycoprotein originally characterized as a cell aggregating factor produced by Sertoli cells and present in high quantities within ram rete testis fluid ( 1, 2) . The human homolog ofclusterin was isolated later as a normal
Portions ofthis work were presented in abstract form at the 1st International Clusterin Workshop, 13-16 September 1992, Cambridge, UK. serum protein present within glomerular immune complex and terminal complement deposits ofpatients suffering glomerulonephritis ( 3 ) . Further characterization led to the demonstration that clusterin was a novel potent inhibitor ofcomplementmediated cytolysis. Indeed, clusterin could specifically bind to the nascent C5b-6 complex, thus suppressing the cytolytic potential of the membrane attack complex of complement (MAC)' by preventing the association of the complex with the plasma membrane and rendering it soluble (4) (5) (6) . The co-localization of clusterin with the MAC in kidney diseases, experimental Heymann nephritis, and lupus skin disease suggests that it also participates in the regulation of the terminal complement cascade in vivo (7) (8) (9) (10) . Human clusterin has also been shown to form a complex with apo A-1 and was independently named NA 1 /NA2 or apo J ( 1 [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . Following density ultracentrifugation, these apo A-1 /clusterin complexes are found in the slow-migrating HDL fraction of fasting plasma, representing -5% oftotal HDL, and it has been suggested that clusterin might thereby serve as a regulator of lipid transport and of local lipid redistribution ( 15, 16) .
Recently, the molecular structure of clusterin has been elucidated by partial amino acid sequencing and cDNA sequencing in several vertebrate species with different phylogenetic distances ranging from the human to the quail (for review see reference 17) . The nucleotide sequence of clusterin, as well as its distribution and its level ofexpression in different tissues has been found to be highly conserved between species, the highest levels of mRNA being detected in the testes, the brain, the adrenal medulla, the liver, the pituitary gland, and the ovary (14, 18, 19) .
Several recent studies have demonstrated an association between clusterin and cell death. Indeed, clusterin mRNA and/ or protein, also known as testosterone-repressed prostate message-2 (TRPM-2), have been shown to be increased in various tissues regressing as a consequence of programmed cell death (PCD), such as in the prostatic epithelial cells after castration (20) (21) (22) (23) , in the renal collecting ducts and distal tubules after ureteral obstruction (20, 24) , and in the rat hippocampus after experimental deafferentation (25) (for review see reference 17).
However, no study has so far demonstrated that the individual cells expressing clusterin in tissues undergoing PCD are actually apoptotic as defined by morphological and biochemical criteria (26) (27) (28) . We have recently shown that human thymocytes undergo PCD during the negative selection process in the absence ofclusterin gene expression, whereas in situ hybridization revealed the presence of clusterin mRNA in surrounding nonapoptotic epithelial cells (29). This finding suggested that clusterin expression was not a prerequisite for the programmed death of thymocytes, and that clusterin is presumably not a death gene in these cells.
To further investigate this hypothesis, we have analyzed five different human cell types for the presence of clusterin mRNA in three different models ofPCD, namely, (a) exposure of U937, HeLa, and A43 1 cell lines to UV-B, (b) in vitro aging of human neutrophils (PMNs), and (c) dexamethasone-induced cell death of the steroid-sensitive lymphoblastoid cell line CEM-C7. The present work demonstrates that, in all cases, PCD (objectivized by the presence of DNA fragmentation and apoptotic cell morphology) correlates with a marked decrease in clusterin gene expression. Interestingly, analysis by in situ hybridization allowed us to demonstrate that during in vitro PCD clusterin mRNA was present only in morphologically normal cells. This strongly suggests that clusterin is not a cell death gene but, on the contrary, that it might be involved in cell survival within a hostile environment where PCD occurs.
Methods
Cells and cell culture. Human epidermoid carcinoma A43 1, human leukemic T cell CEM-C7 (30) , and human histiocytic lymphoma U937 cell lines were grown in RPMI 1640 medium (Gibco, Grand Island, NY) supplemented with 5% (U937) or 10% (A431, CEM-C7) FCS (Gibco). Human cervix carcinoma HeLa cells were grown in DMEM medium (Gibco) supplemented with 10% FCS. All media contained 110 IU/ml penicillin (Gibco) and 110 ,ug/ml streptomycin (Gibco). These lines were maintained in exponential growth, at 370C in a humidified 5% C02/95% air atmosphere, harvested at subconfluency with EDTA 3 mM/trypsin 0.5% (A43 1, HeLa) and reseeded in fresh medium 24 or 48 h before each experiment so as to be -70% confluent at the start of the experiment.
Isolation ofPMNs. PMNs were isolated from fresh buffy coats of normal donors using a Ficoll-Paque gradient (Pharmacia AB, Uppsala, Sweden) and hypotonic erythrocyte lysis with minor modifications brought to the technique described (31). Briefly, the buffy coat obtained from -400 ml of normal donor blood was diluted 1:1 vol in PBS/EDTA 2 mM, mixed gently with 0.25 vol of 4% Dextran T 500 (Pharmacia AB), left 30 min for erythrocyte sedimentation after which the leukocyte-rich supernatant was collected and centrifuged 10 min at 200 g. The pellet was resuspended in 9 ml distilled water to lyse erythrocytes, returned to isotonicity after 40 s by addition of 3 ml 0.6 M KCl and of 40 ml 0.15 M NaCl, centrifuged 10 min at 350 g, and resuspended in 20 ml PBS/EDTA 2 mM. This suspension was layered over 20 ml Ficoll-Paque (Pharmacia AB), centrifuged 30 min at 350 g, and the PMN-rich (> 98% pure, > 99% trypan blue exclusion) pellet recovered, washed twice in PBS/EDTA 2 mM, before resuspension at 5 x 106/ml in RPMI supplemented with 5% heat-inactivated FCS and incubation at 37°C under standard culture conditions.
All manipulations were performed under sterile conditions at 4°C to minimize neutrophil activation and aggregation.
Models ofPCD. In U937, HeLa, and A43 1 cells, PCD was induced as described (32) , by exposure from above to a 254-nm UV-B source at a distance of 20 cm for 10 min at room temperature and then returned to 37°C for 4 or 24 h.
PMNs were aged in vitro by placing them in RPMI medium supplemented with 5% heat-inactivated FCS under standard culture conditions for 4 to 24 h, time 0 corresponding to the time at which freshly isolated PMNs were resuspended in culture medium. Under similar conditions, PMNs have been shown to undergo time-related morphological and biochemical modifications characteristic of PCD (33) . PCD was induced in CEM-C7 cells by incubation in the presence of 10-6 M dexamethasone (Organon Teknika, Pflffikon, Switzerland) as described (30) , for variable time periods ranging from 30 min to 96 h.
Histology. Cytospin preparations were performed with cells collected at different time intervals, air-dried, and stained with MayGrunwald-Giemsa combination (Fluka Chemie AG, Buchs, Switzerland) or hematoxylin-eosin. Cell viability was assessed on 200 cells by trypan blue exclusion (Merck AG, Darmstadt, Germany). Microphotographs were taken with a photomicroscope (Carl Zeiss, Oberkochen, Germany), using Kodak Ektachrome T64 color film.
DNA fragmentation analysis. Fragmented DNA was isolated essentially as described (34) . Briefly, cells were collected, centrifuged 10 min at 200 g, lysed for 10 min in 1 ml hypotonic lysis buffer(Tris 5 mM, pH 7.4, EDTA 5 mM, Triton X-100 0.5%) and re-centrifuged 15 min at 13,000 g to sediment high molecular weight DNA. Supernatants were extracted once in phenol/chloroform ( 1:1, vol/vol; plus 2% isoamyl alcohol) and twice in chloroform/isoamyl alcohol (24:1 ), precipitated overnight at -20'C in 50% isopropanol + 130 mM NaCl, washed in 70% ethanol, dried, resuspended in 10 Ml Tris 10 mM, pH 8.1 + EDTA 1 mM, and migrated for 3 h at 30 V in a 1.2% agarose minigel containing 30 gg/ml ethidium bromide (EtBr). Samples were not treated with RNAse. Photographs of the gels were taken under UV transillumination with a Polaroid camera.
Plasmid constructions, in vitro transcription, and Northern blot analysis. The clusterin sense and antisense probes were prepared from pGEM-4 ZLI, containing the full-length human clusterin cDNA (35) . The chicken GAPDH antisense probe was prepared from pSP64cGAPDH containing the 1. 1-kb chicken muscle glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA (36) , and the human f3-actin antisense probe from pSP64-fl-actin containing the 600-bp BamH l-EcoR I fragment of 3' untranslated human fl-cytoskeletal actin (37) . 3H-labeled probes were reduced to an average size of 50-100 nucleotides by mild alkaline hydrolysis as previously described (38) . Total RNA was extracted as described elsewhere (39) . RNAs were denatured with glyoxal, electrophoresed in 1.2% agarose gels, and transferred overnight onto Hybond nylon membranes (Hybond-H; Amersham International). Prehybridizations, hybridizations, and posthybridization washes were carried out as described (38) .
In situ hybridization. Minor modifications were brought to the procedure previously described (38) . Cultures of A43 1 cells and cytospins of U937 cells were performed on poly-L-lysine (Sigma Chemical Co., St. Louis, MO) coated microscope slides, fixed in 4% glutaraldehyde in PBS for 1-5 min, rinsed in PBS, and stored in 70% ethanol at 4°C until analyzed. 0.4-1 x IO1 cpm of 3H-labeled cRNAs were applied to each section in 20-70 Ml of hybridization mixture. After graded ethanol dehydration, sections were immersed in a 1:1 dilution ofNTB-2 emulsion (Eastman Kodak, Co., Rochester, NY) in deionized water. After 12 wk exposure, sections were developed in Kodak D-19 developer, fixed in 30% Na thiosulfate, and counterstained with 1% methylene blue. Hybridizations using the sense cRNA probe were performed as controls of specificity. Microphotographs were taken with a photomicroscope (Carl Zeiss), equipped with an immersion dark-field condenser, using Kodak Ektachrome T64 color film.
Results
Only surviving cells continue to express the clusterin gene after UV induction ofPCD. Exposure ofcells to UV-B for periods of time ranging from 5 to 30 min has been shown to induce PCD in myelomonocytic, T and B-lymphoblastoid as well as preerythroid cell lines, whereas longer periods of exposure lead to cell necrosis (32) . In order to evaluate clusterin gene expression in cells of myeloid and epithelial origin dying as a consequence of PCD, we exposed these cells for a short period of time to a source of UV-B. Following a 10-min exposure to UV-B, most U937 cells develop characteristic signs of apoptosis, including cytoplasmic condensation, nuclear condensation and fragmentation, cellular blebbing, and eventually separation of the cells into clusters of membrane enclosed segments or "apoptotic bodies" (Fig. 1 B) . These cells also show marked internucleosomal fragmentation of cellular DNA already 4 h after UV-exposure (Fig. 2, lane b) dogeneous endonuclease activation and is not the result of direct UV-induced DNA damage, as no fragmentation was detectable immediately after UV irradiation (Fig. 2, lane a) . A similar pattern of fragmentation was also observed after exposure of HeLa and A431 cells to UV-B (not shown). Northern blot analysis of total RNA extracted at different time intervals after UV-exposure revealed a marked decrease in clusterin expression in the three cell lines (Fig. 3) .
Analysis of U937 cells at different time intervals after UV-B exposure by in situ hybridization revealed little or no clusterin message within apoptotic cells, but considerable levels of clusterin mRNA in surviving cells that were morphologically normal (Fig. 4) (44); Mullerian ducts, which participate in the formation ofuterine and Fallopian structures in mammalian females, regress in males through PCD (45); the tadpole metamorphosis involves the programmed death of tail cells (46, 47) ; and the development and differentiation of the vertebrate nervous system requires the PCD-mediated selective elimination of neurons (48, 49) . In the adult, PCD might also be required in the control ofcell growth and proliferation; for instance, the daily elimination ofmillions ofcirculating PMNs has been shown to be programmed (33) . Although the exact molecular mechanism by which PCD takes place remains to be elucidated, the requirement of gene transcription and RNA translation for cell death to occur (50, 51 ) strongly argues in favor of an active mechanism. Great interest has recently been given to the search for RNAs specifically synthesized before or during PCD. One such gene, TRPM-2, has been cloned from regressing rat ventral prostate tissue, and is the rat species homologue ofhuman clusterin (52, 53) . Expression of this gene has been shown to be increased in numerous rodent models ofPCD, including prostate regression after orchiectomy (20, 54) , cytotoxic tumor regression (20) , and renal tubular atrophy during hydronephrosis (20, 21, 55) . Taken together, these observations clearly show that, in whole tissue extracts, PCD is associated with elevated TRPM-2/clusterin levels. However, the major drawback of these studies resides in the lack of information on the functional status of the cells synthesizing clusterin mRNA: Are they cells undergoing PCD, cells that are about to undergo PCD, or cells that escape PCD? To address this question, we have analyzed clusterin gene expression in human cell cultures using three different models of PCD. In all cases, cells were shown to develop characteristic morphological features of PCD, including cytoplasmic and nuclear condensation, cellular blebbing, and nuclear fragmentation, as well as a typical pattern of DNA degradation into oligonucleosome-sized fragments. Surprisingly, however, a rapid and marked decrease in clusterin mRNA was observed in U937, HeLa, and A43 1 cells undergoing PCD after a short exposure, and, in addition, it clearly demonstrated that, in contrast to morphologically preserved surviving cells, which express stable levels of clusterin mRNA, apoptotic cells contained no clusterin mRNA. To exclude the possibility that the The results presented here are in agreement with the recent observation made by Garden et al. demonstrating a lack of correlation between neuronal cell death and neuronal SGP-2 (the rat homologue ofhuman clusterin) mRNA content within the central nervous system (56) . Similarly, in a recent study of clusterin gene expression in the human thymus we also found a lack of correlation between thymocyte apoptosis and clusterin gene expression (29). In this case, only nonapoptotic thymic epithelial cells were shown to contain clusterin mRNA. Finally, the constitutive expression ofclusterin by a great number of healthy cells ( 1, 2, 19, 57) also argues against the possibility that the clusterin gene encodes a lethal gene product, and supports the proposed association of clusterin with cell survival.
The apparent discrepancy between our results and the high levels of clusterin mRNA detected in tissues regressing as a consequence of PCD (20, (52) (53) (54) (55) could possibly be due to the fact that clusterin gene expression is not a molecular feature of cells undergoing PCD, but rather that of cells not undergoing PCD, within the tissue where PCD takes place. This hypothesis is supported by our present observations and by those previously made in the human thymus (29), although we did not detect an increase in clusterin gene expression within nonapoptotic cells. Under these circumstances, clusterin could have a protective role in a tissue containing cells undergoing PCD; its potent inhibitory activity against complement-mediated cytolysis (4, 5, 6, 35) playing a part in maintaining minimal inflammation. Clusterin has also recently been identified as an HDLassociated protein, quite similar to apoE, a protein that has been shown to be secreted by resident macrophages of the rat sciatic nerve after crush injury and to participate in local cholesterol transport during regeneration and remyelination (58) . This similarity, among others, suggests that clusterin secretion by cells not undergoing PCD may, like apoE, help with the removal and redistribution ofnonphagocyted membrane lipids originating from apoptotic cells ( I I-16 6).
In conclusion, we 
